Ferulic acid ameliorates nerve injury induced by cerebral ischemia in rats
This study was designed to investigate the protective effect of ferulic acid (FA) on nerve injury induced by cerebral ischemia. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery and reperfusion 90 min later in male Sprague-Dawley rats. Daily treatment of the rats with FA was initiated 30 min after the surgery, and was continued for 7 days. The efficacy of FA against nerve injury was assessed by neurological deficit scores as well as pathohistological observation. The expression levels in the brain and level in the peripheral blood of erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) were analyzed by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA), respectively. The results showed that FA attenuated nerve injury of the hippocampus, significantly ameliorated neurological deficits, and increased EPO but not G-CSF expression in the hippocampus and the peripheral blood of ischemic rats. The findings indicate that FA has certain protective effects on the nerve injury of cerebral ischemia, and suggest that promoting EPO in the brain and peripheral blood may be one of the neuroprotective mechanisms of FA.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Experimental and therapeutic medicine - 9(2015), 3 vom: 08. März, Seite 972-976 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Leiming [VerfasserIn] |
---|
Themen: |
Cerebral ischemia |
---|
Anmerkungen: |
Date Revised 01.10.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM246103566 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM246103566 | ||
003 | DE-627 | ||
005 | 20231224142338.0 | ||
007 | tu | ||
008 | 231224s2015 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0820.xml |
035 | |a (DE-627)NLM246103566 | ||
035 | |a (NLM)25667662 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Leiming |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ferulic acid ameliorates nerve injury induced by cerebral ischemia in rats |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Revised 01.10.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a This study was designed to investigate the protective effect of ferulic acid (FA) on nerve injury induced by cerebral ischemia. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery and reperfusion 90 min later in male Sprague-Dawley rats. Daily treatment of the rats with FA was initiated 30 min after the surgery, and was continued for 7 days. The efficacy of FA against nerve injury was assessed by neurological deficit scores as well as pathohistological observation. The expression levels in the brain and level in the peripheral blood of erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) were analyzed by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA), respectively. The results showed that FA attenuated nerve injury of the hippocampus, significantly ameliorated neurological deficits, and increased EPO but not G-CSF expression in the hippocampus and the peripheral blood of ischemic rats. The findings indicate that FA has certain protective effects on the nerve injury of cerebral ischemia, and suggest that promoting EPO in the brain and peripheral blood may be one of the neuroprotective mechanisms of FA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cerebral ischemia | |
650 | 4 | |a erythropoietin | |
650 | 4 | |a ferulic acid | |
650 | 4 | |a nerve injury | |
700 | 1 | |a Wang, Hongsheng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Tian |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Na |e verfasserin |4 aut | |
700 | 1 | |a Yu, Pengfei |e verfasserin |4 aut | |
700 | 1 | |a Chong, Yating |e verfasserin |4 aut | |
700 | 1 | |a Fu, Fenghua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental and therapeutic medicine |d 2010 |g 9(2015), 3 vom: 08. März, Seite 972-976 |w (DE-627)NLM206343205 |x 1792-1015 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2015 |g number:3 |g day:08 |g month:03 |g pages:972-976 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2015 |e 3 |b 08 |c 03 |h 972-976 |